Target intelligence / Profile preview

23S ribosomal RNA peptidyl-tRNA site (P-site) of the 50S bacterial ribosomal subunit (23S rRNA P-site)

Target
23S rRNA P-site
Molecular classification
Ribosomal RNA, Bacterial ribosome component, Ribonucleic acid
01

Overview

The 23S ribosomal RNA (rRNA) P-site (peptidyl-tRNA site) is a highly conserved functional domain within the 50S large subunit of the bacterial ribosome (NCBI, 2023). It serves as the critical binding site for the tRNA molecule carrying the growing polypeptide chain during the elongation phase of translation (PubMed, 2021). Located at the heart of the peptidyl transferase center (PTC), the P-site is essential for catalyzing peptide bond formation by orienting the peptidyl-tRNA to react with the incoming aminoacyl-tRNA in the A-site (Nature, 2017). This site is a major pharmacological target for several classes of antibiotics, most notably the oxazolidinones (e.g., Linezolid) and pleuromutilins (e.g., Lefamulin), which bind to the PTC and physically obstruct the binding or movement of tRNA (StatPearls, 2023). Disruption of P-site function effectively halts bacterial protein synthesis, leading to bacteriostatic or bactericidal effects depending on the pathogen. Clinical resistance often involves point mutations in the 23S rRNA, such as the G2576T substitution, or the acquisition of methyltransferase enzymes like Cfr that modify the rRNA to prevent drug binding (PubMed, 2020).

Other names
Peptidyl-tRNA siteP-site of the 50S subunit23S rRNA peptidyl transferase center P-siteRibosomal P-site
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the peptidyl transferase center (PTC) and preventing the proper positioning or translocation of peptidyl-tRNA, thereby halting peptide bond formation.

03

Biological functions

Protein synthesisTranslation elongationPeptidyl transferase activitytRNA binding
04

Disease associations

Bacterial infection
05

Safety considerations

Mitochondrial protein synthesis inhibition due to structural homology with human mitochondrial ribosomesMyelosuppression associated with prolonged use of oxazolidinonesRapid emergence of multidrug resistance through rRNA mutations or enzymatic modification
06

Interacting drugs

Linezolid

6 more in the full profile.

07

Biomarkers

23S rRNA G2576T mutationCfr ribosomal methyltransferase expressionVga(A) ABC-F protein expression

Beyond the preview

Go deeper on 23S ribosomal RNA peptidyl-tRNA site (P-site) of the 50S bacterial ribosomal subunit (23S rRNA P-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA peptidyl-tRNA site (P-site) of the 50S bacterial ribosomal subunit (23S rRNA P-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call